Anticoagulation (DBCOND0033132)

Identifiers

Synonyms
Not Available

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Lepirudin
A protein-based direct thrombin inhibitor used as an anticoagulant in patients with heparin-induced thrombocytopenia.
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT05256303
Rural Hospital-Level Care at Home for Acutely Ill AdultsNo drug interventionstreatmentNot Availablecompleted
NCT02526303
Anticoagulation for Non-occlusive Portal Vein Thrombosis in Patients With Liver CirrhosistreatmentNot Availablewithdrawn
NCT05191290
Comparison of Biocompatibility of Plasmapheresis Procedures With Citrate and Heparin Anticoagulationtreatment4completed
NCT01267487
Clinical Trial Comparing Heparin and Protamine Fixed and Titrated Doses in Cardiac Surgery With Cardiopulmonary Bypassprevention4completed
NCT03910933
Electronic KIDCLOT Interactive Thrombosis/Thrombophilia Education; A Quality Assurance InitiativeNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT01269905
Choice of Valve Substitute in the Era of Oral Anticoagulation Self-ManagementNo drug interventionsNot AvailableNot Availablecompleted
NCT01477528
Study of Reduced Anti-coagulation/Anti-platelet Therapy in Patients With the HeartMate II Left Ventricular Assist System (LVAS) (TRACE)No drug interventionsNot AvailableNot Availablecompleted
NCT02492828
Adherence of Apixaban and Warfarin in Patients With Arterial Fibrillation in Real-world Setting in SwedenNo drug interventionsNot AvailableNot Availablecompleted
NCT03473132
Assessment of Coagulation Factor Levels in Left Ventricular Device (LVAD )Patients Following Temporary Warfarin Reversal With Four Factor Prothrombin Complex Concentrate (4F-PCC)treatment4unknown_status
NCT02591732
A Nationwide Registry Study of Patients With Nonvalvular Atrial Fibrillation Initiating Oral Anticoagulation Therapies In The Early Period Following Apixaban Marketing In DenmarkNo drug interventionsNot AvailableNot Availablecompleted
NCT04405232
Coagulopathy in COVID19 - A Multi-Centre Observational Study in UKNo drug interventionsNot AvailableNot Availableunknown_status
NCT00205400
Comparison of Patient Outcomes Using Different Delivery Models of Anticoagulation CareNo drug interventionstreatmentNot Availablecompleted
NCT04344717
Pharmacokinetics of Apixaban in Patients With Short Bowel Syndrome Requiring Long Term Parenteral Nutritiontreatment4recruiting
NCT02074358
A Study to Assess the Effects of 2 Prothrombin Complex Concentrates on the Pharmacodynamics of Apixaban in Healthy Adult Subjectsbasic_science1completed
NCT01124058
Evaluation of Maintenance Dosing vs Loading Dosing Upon Restarting Warfarin Therapy: A Prospective Randomized Trialtreatment1completed
NCT02640222
APIXABAN in the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation in Real-Life Setting in France SNIIRAM StudyNot AvailableNot Availablecompleted
NCT04139525
Comparison of Citrate and Heparin Anticoagulation During Hemodialysis With MCO PES-PVP (Theranova) MembranetreatmentNot Availableunknown_status
NCT04059965
AntiCoagulation Tracking InterVention and EvaluationNo drug interventionstreatmentNot Availablewithdrawn
NCT02987192
Minimally Invasive Lumbar Aneasthesia Used for Cesarean SectionNo drug interventionstreatmentNot Availableunknown_status
NCT03684395
Accessibility to New Drugs Versus SOC in SwedenNot AvailableNot Availablecompleted
NCT03419923
Three Anticoagulation Strategies for Hemodialysis in Patients at Risk of HemorrhagetreatmentNot Availableunknown_status
NCT06272708
Preliminary Exploration of Thromboelastography in the Monitoring of Anticoagulation in Maintenance Hemodialysis PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT00329290
Evaluation of Maternal and Fetal Outcomes in Pregnancies in Women With Prosthetic Heart ValvesNo drug interventionsNot AvailableNot Availablecompleted
NCT04071171
Comparison of Biphozyl® and Phoxilium® as a Replacement Fluid During CVVH for AKI in Adults and Their Effects on pH-, Bicarbonate-levels and Respiratory Situationtreatment2completed
NCT01884337
Multi-center Study to Evaluate the Safety of Apixaban (BMS-562247) in Indian Subjects Undergoing Elective Total Knee Replacement or Total Hip Replacement Surgerytreatment4completed
NCT05782270
Antithrombotic Therapy After Coronary Artery Bypass Grafting Combined With Coronary Endarterectomytreatment4recruiting
NCT03575936
Enhanced Pharmacist-Managed Anticoagulation Service in a University-based Family Medicine ClinicNo drug interventionssupportive_careNot Availablecompleted
NCT05555641
Efficacy and Safety of Nafamostat Mesylate for VV-ECMO Anticoagulationtreatment2recruiting
NCT02761941
Excessive Warfarin Anticoagulation - Causes and ConsequencesNo drug interventionsNot AvailableNot Availableunknown_status
NCT02427516
Cost of Monitoring Patients Treated With Vitamin K Antagonists in SpainNo drug interventionsNot AvailableNot Availablecompleted
NCT01314235
Influence of Clonidine on Thrombozytes of Blood of Patients Under Anticoagulation Therapy With ASS and ClopidogrelNo drug interventionsNot AvailableNot Availableunknown_status
NCT01907048
Patient and Physician Knowledge of Key Safety MessagesNo drug interventionsNot AvailableNot Availablecompleted
NCT02921126
Real-World Evidence of Anticoagulation Treatment In Non-Valvular Atrial Fibrillation In ItalyNo drug interventionsNot AvailableNot Availablecompleted
NCT02705976
Prospective Trial of a Validated Algorithm for Warfarin DosingNo drug interventionssupportive_careNot Availablecompleted
NCT03662594
Growth of High-Quality Oxides on The Inner Surface of ECMO Circuit by ALD to Reduce Thrombus FormationNo drug interventionssupportive_careNot Availablecompleted
NCT03996629
Impact of Clinical Pharmacist Interventions in Vitamin K Antagonists Management at One Teaching Hospital in VietnamNo drug interventionspreventionNot Availableunknown_status
NCT06209892
Prolonged Anticoagulation Therapy on the Prognosis of Patients With Left Ventricular ThrombosisNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT06476301
Efficacy and Safety of Rivaroxaban in the Early Postoperative Period for Patients With Bioprosthetic Valvesprevention4not_yet_recruiting
NCT04539301
Multicentric Prospective Validation of a Universal Test to Quantify Apixaban, Rivaroxaban, Danaparoid and Fondaparinux LevelsNo drug interventionsNot AvailableNot Availablerecruiting
NCT02392104
Prospective Evaluation of an Extended Interval of INR Follow-up in a VA Anticoagulation ServicetreatmentNot Availablecompleted
NCT05305612
Optimal PeriproCeduraL AnticOagulation in Structural Transseptal InterventionsNo drug interventionstreatment4enrolling_by_invitation
NCT02714855
Apixaban in the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation in Real-Life Setting in FranceNot AvailableNot Availablecompleted